Arkolith/Insider Trading/ZBIO/Form 4

Lu Hongbo

DirectorZenas BioPharma, Inc. (ZBIO) · full profile →Form 4 · filed Mar 31, 2026
Net Buying
Open-Market Buys
$1.5M
Open-Market Sells
$0
Net Open-Market Flow
$1.5M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2026Buy(P)75K$20.00$1.5M423K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-037865) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML